<< Read Full Article
<< Read Full Article
Genzyme's Sales Fall Short
- Loading Comments...
Genzyme(GENZ Quote) exceeded Wall Street's earnings expectations but fell short of analysts' sales estimates for the third quarter.
Shares of Genzyme dropped 4.4% to $65.
The company earned $16 million, or 6 cents a share, compared with $115.7 million, or 43 cents a share, in the year-ago period. This year, earnings included a series of expenses that cut Genzyme's profits, including a $149.4 million charge related to the company's genetic-testing business. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,471.58 | 1,108.86 | 2,175.81 | 32.75 |
Oil *
79.69
|
|
UP
126.74
|
UP
13.23
|
UP
31.21
|
UP
0.74
|
10 Yr
3.28%
SPDR Gold
117.38
|
|
+1.23%
|
+1.21%
|
+1.46%
|
+2.31%
|
Data delayed 20 minutes |


Connect with TheStreet